Metraipolis › archive › dc_dd2a333be318
CD137 in tuberculosis: a scoping review of an emerging immune checkpoint at the crossroads of diagnosis, prognosis, and therapy — Europe PMC PMID:41256867
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41256867
- DOI
- 10.3389/fimmu.2025.1682269
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:52:08.597Z
- SHA-256 of the archived text
bfdc2462413f943cbc9319f16abe5be49a48684812e0ca2ba990bf6d169256c1- Stable URL of this page
https://metraipolis.com/documento/dc_dd2a333be318
How to cite
CD137 in tuberculosis: a scoping review of an emerging immune checkpoint at the crossroads of diagnosis, prognosis, and therapy — Europe PMC PMID:41256867 — Europe PMC (en), https://europepmc.org/article/MED/41256867 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd2a333be318 (Metraipolis archive dc_dd2a333be318, sha256 bfdc2462413f943cbc9319f16abe5be49a48684812e0ca2ba990bf6d169256c1)
BibTeX
@misc{dcdd2a333be318,
title = {CD137 in tuberculosis: a scoping review of an emerging immune checkpoint at the crossroads of diagnosis, prognosis, and therapy — Europe PMC PMID:41256867},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41256867},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd2a333be318; sha256 bfdc2462413f943cbc9319f16abe5be49a48684812e0ca2ba990bf6d169256c1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41256867. Agents can read the archived copy with the MCP tool read_document.